Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialÉric Deutsch, D. Azria, C. Lemanski et al.|Annals of Oncology|2013Cited by 89
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trialAntonin Lévy, Éric Deutsch, D. Azria et al.|Radiotherapy and Oncology|2015Cited by 38
Reply to R. Glynne-Jones et alD. Peiffert, Michel Ducreux, L. Tournier-Rangeard et al.|Journal of Clinical Oncology|2012Cited by 0
Cancer of the head and neckD. Leignel, M. Houjami, A. Banal et al.|Cancer/Radiothérapie|2005Cited by 0